Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients

NCT02178540 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Placebo
DEVICE: Tobi Podhaler

Sponsor

Novartis Pharmaceuticals